Animal funds

Companion Animal Health Market Report 2022: Rising Government and Animal Welfare Initiatives Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Companion Animal Health Market Research Report by Animal (Cats, Dogs, and Horses), Indication, Type, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East, and Africa) – Global Forecast until 2027 – Cumulative impact of COVID-19[FEMININE”[FEMININE” report has been added to from ResearchAndMarkets.com offer.

The global companion animal health market size was estimated to be USD 24.45 billion in 2021, USD 28.72 billion in 2022, and is projected to grow at a CAGR of 17.62% to reach USD 64.77 billion. by 2027.

Market statistics:

The report provides market size analysis and forecasts for 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD and CHF. It helps organizational leaders make better decisions when currency data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year and the years from 2023 to 2027 as the forecast period.

Segmentation and market coverage:

This research report categorizes Companion Animal Health to forecast revenues and analyze trends in each of the following submarkets:

  • Based on Animal, the market has been researched for Cats, Dogs, and Horses.

  • Based on the indication, the market has been studied on behavioral disorders, dental diseases, dermatological diseases, infectious diseases and orthopedic diseases.

  • On the basis of type, the market has been studied for medicinal food additives, nutritional food additives, pharmaceuticals and vaccines. The medicinal additive food is studied in more detail through amino acids, minerals and vitamins. Nutritional food additives are further studied in enzymes, food acidifiers, hormones, immune modulators, and prebiotics and probiotics. Pharmaceuticals are further studied in anti-inflammatories, antibiotics, ectoparasiticides and endoparasiticides.

  • On the basis of end user, the market has been studied in retail pharmacies and veterinary hospitals.

Competitive Strategy Window:

The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.

FPNV positioning matrix:

The FPNV Positioning Matrix evaluates and categorizes the Companion Animal Health Market vendors based on business strategy (business growth, industry coverage, financial viability, and channel support) and product satisfaction (value for money, ease of use, product features and customer). Support) that helps businesses make better decisions and understand the competitive landscape.

Market share analysis:

The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of ​​its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of ​​the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.

Market dynamics

Drivers

  • Multiply the initiatives of the government and animal protection associations

  • Technological advances in the field of animal health

  • Changing consumer perception of pet health and extending pet life expectancy

  • Increase disposable income and allow pet owners to spend more on pet health care

  • Rise in online shopping and home delivery drives product sales

Constraints

  • Increase in cheap counterfeit drugs

  • Lack of infrastructure, funding and standardization

Opportunities

  • Increase in cheap counterfeit drugs

  • Lack of infrastructure, funding and standardization

Challenges

  • Ban on the use of antibiotics and antimicrobials in animal feed in many countries,

  • High cost associated with animal and veterinary testing in developing countries

Main topics covered:

1. Preface

2. Research methodology

3. Executive Summary

4. Market Overview

5. Market Overview

6. Companion Animal Health Market, By Animal

7. Companion Animal Health Market, By Indication

8. Pet Healthcare Market, By Type

9. Companion Animal Healthcare Market, By End User

10. Americas Companion Animal Health Market

11. Asia-Pacific Companion Animal Health Market

12. Europe, Middle East and Africa Companion Animal Health Market

13. Competitive landscape

14. Company Usability Profiles

15. Appendix

Companies cited

  • Alcami Company

  • B. Braun Melsungen AG

  • Bayer AG

  • Bioiberica SAU

  • Boehringer Ingelheim GmbH

  • Ceva Animal Health SA

  • cozmix inc.

  • Dechra Pharmaceuticals PLC

  • Elanco Animal Health Incorporated

  • Elanco US, Inc.

  • Eli Lilly and company

  • IDEXX Laboratories, Inc.

  • Medtronic APIs

  • Merck & Co., Inc.

  • MSD Animal Health Srl

  • Nutreco S.A.

  • Perrigo Company PLC

  • Vetoquinol SA

  • Virbac SA

  • Zoetis, Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/wfn7bk